Categories

Category: Kim Bellard

Science FTW

By KIM BELLARD

Science won. At least, that’s one of the takeaways from last week’s midterm elections. If you were one of the 124 million Americans who voted, you probably already know that there was a Blue Wave, with resounding Democrat victories across the country, even in historically red areas.

Georgia not only reelected its Democrat Senator – no surprise — but also elected a Democrat Governor, who will be the first black woman governor in the country, no less. Iowa elected a Democrat Senator and Governor. South Carolina is sending a Democrat to the Senate, and Mississippi – Mississippi!!! – may as well. Even Kansas elected a Democrat Senator, the first such in almost 100 years. Ohio and Texas not only flipped their Senators and Governors but Democrats won all the statewide elections.

Truly strange times.

I’m allowing myself to hope that we’ll finally have a Congress that will fulfill its constitutional duties of acting as a counterbalance to the power of the Presidency, but one thing I’m particularly excited about is the prospect these results will be less about being a Blue wave than what The Washington Post called a “STEM wave.” Among the newcomers to Congress are a record number of physicians and scientists. They’re going to have their hands full.

Much has been written (including by me) about the Trump Administration’s attacks on science. Just last week The New York Times reported on How Trump Is Dismantling America’s Scientific Research Machine. Amid cuts in research grants, resignations and firings of top scientists, departures of leading scientists to other countries, and reductions in Ph.D. students, the Defense Department warned that its “innovation engine is at risk of stalling.” Even people who aren’t defense hawks should realize that spells big trouble for American science in general, and for all of us.

A year ago I wrote about how organizations like 314 Action and Stand Up for Science were leading the resistance to the attacks on science. 314 Action, for example, spent some $23 million on pro-science candidates, doubling its 2024 donations. Shaughnessy Naughton, president of 314 Action, told Alexander Nazaryan of The New York Times that the election results, especially the incoming scientist lawmakers, represent “a real repudiation of what has been two terrible years for science and public health.”

Continue reading…

Putting the “AI” in “Legal” (and “Health Care”)

By KIM BELLARD

I once again have to thank The New York Times for introducing me to a new concept. Sarah Kessler wrote about the rise of “legal engineering” – for which, it turns out, one doesn’t have to be either a lawyer or an engineer.

Their role is to help integrate A.I. into the practice of law, whether at law firms or companies. That sure sounds like a prudent, if possibly belated, idea – and one suspects we’re going to see such “engineers” in other fields. I certainly hope that healthcare is one of them, sooner rather than later.

Irene Liu, the executive director of the A.I. initiative at Stanford Law School, explained the job to Ms. Kessler thusly: “If you were to just put it into an equation, it’s law plus technology plus business process.” That Venn diagram gets pretty small very quickly.

Mary O’Carroll, the C.E.O. of LegalEng Consulting Group, also explained the role to Ms. Kessler: “You don’t necessarily need a giant pyramid of lawyers anymore. People who have this kind of skill set don’t have to have a J.D., and they don’t have to be software engineers, but there’s business process re-engineering, or this M.B.A. type skill, that I think is really necessary.”

Ms. Kessler notes that they are sometimes referred to as “knowledge and innovation counsels,” “innovation attorneys,” or “legal applications engineers,” which may illustrate that the role is both new and evolving.

If you’re considering why this role is important, note that the 2026 Legal Industry Report from 8am™ found that 69% of legal professionals report personally using Generative AI (GenAI) tools such as ChatGPT, Gemini, or Claude for work-related purposes, up from 31% a year earlier.

Continue reading…

I’d Like Some Choices, Please

By KIM BELLARD

Let’s say your favorite social media platform is bought by a right wing trillionaire, who espouses free speech, but only when it echoes his. You can switch to, say, Threads, but – whoops – that’s owned by Mark Zuckerberg, another of the super-rich who have turned to the right. There’s always Facebook but – damn! – Zucked again! So you migrate to Bluesky, where the discourse is more civil but the audiences admittedly smaller. At least you have some choices.

Not so much if, say, you are the President of Ukraine. Ukraine has unexpectedly held off the much bigger Russia for over four years now, in the process reinventing modern warfare by turning it from the traditional men, tanks, and artillery to a technology-powered war, especially with drones. To do so, it relied heavily on Starlink and its Pentagon-version Starshield. Unfortunately, Ukraine was blindsided a couple weeks ago when Starlink speeds were drastically lowered. Drones were literally falling out of the sky.

President Zelensky raised the alarm. Secretary of State Rubio said he thought software “glitches” were to blame, but most people suspected either Starlink’s owner Elon Musk and/or President Trump. Mr. Musk pointed fingers at the Pentagon, President Trump blamed Mr. Musk, and for several days Ukraine was hampered. Finally Mr. Musk admitted he’d ordered the slowdown, saying Ukraine had violated the “terms of service” of the service, using it “for offensive drone strikes to kill people.”

Note that Serhii Beskrestnov, a Ukrainian presidential adviser on military technology, wrote on social media “we are PHYSICALLY UNABLE TO USE COMMERCIAL STARLINK for deep strikes or medium-range strikes.”

The “loophole was closed last week,” according to both Mr. Musk and President Zelensky, with normal speeds resumed, but if you were President Zelensky you’d sure have to be looking for alternatives, as you’d never know when the equally mercurial Mr. Musk or President Trump might pull another Lucy on you (Gen Z: check your “Peanuts” references).

Unfortunately, there really aren’t any, and that’s a problem.

Continue reading…

Enough of Asshole Capitalism

By KIM BELLARD

I recently read both Plastic, Inc. (Beth Gardiner) and These Are the Plunderers (Gretchen Morgenson and Joshua Rosner), and, boy, am I mad. Nothing in either book really came as a surprise, but the degree to which some people are willing to be greedy at the expense of others is still daunting. The latter introduced me to the phrase “Asshole Capitalism,” a phrase that comes from the work of Aaron James, a philosophy professor at University of California, Irvine. It can be summed up as a system where “citizens feel entitled to unlimited personal enrichment even at social cost.”

In other words, capitalism. No wonder a recent survey found that 43% of U.S, adults view socialism favorably (although Vice President J.D. Vance finds it a hard term to define and seems to think it has to do with foreign workers and transgender athletes).

Plastic, Inc. tells the story of how, over the course of several decades, the petrochemical industry has worked to have us consume ever more plastic while not only absolving themselves of the responsibility for what happens to all that plastic but also boldly attempting to make consumers feel guilty about not doing a better job of recycling it. Those of us of a certain age might remember the “Crying Indian” littering ad. Well, that ad was sponsored and paid for by the industries that were producing the litter.

These Are the Plunderers shows how private equity firms blithely take companies and strip them of valuable assets, enriching themselves while often essentially destroying the companies. The authors focus much attention on healthcare, such as nursing homes or emergency room staffing, in which private equity ownership leads to demonstrably higher costs, job cuts, and worse care, while making boatloads of money for the private equity owners. Manufacturing, retailing, and other industries have also had victims.

Capitalism is replete with disregard for the common good. E.G., the fossil fuel industry giving us cheap gas without being responsibly for the ensuing climate change, mining companies that strip the earth while wrecking ecological damage on the environment, or manufacturers that pollute their local communities then close the factories when asked to clean up their waste. Capitalism has a very bad habit of not recognizing either costs imposed on others or costs to clean up their actions. It’s someone else’s problem, and that someone else usually ends up being those of us who pay taxes, or whose health is deemed unimportant.

Cancer alley is no secret, nor are the health risks of the fracking craze that has supercharged the profits of oil & gas companies. We’re becoming more aware of how pervasive microplastics are, and just starting to realize how bad that is for us.

Continue reading…

Healthcare Is Fighting the Wrong AI War

By KIM BELLARD

The Blue Cross Blue Shield Association is crying wolf about AI. Its new analysis claims that “hospital systems are increasingly billing patient hospital stays as more medically complex,” and that these upcodings cost BCBS plans almost $1b from 2023 to 2025. That’s just claims from hospital systems, just to BCBS plans, so the total number could be much higher.

Well, you might say, a billion here, a billion there – that’s just healthcare these days. Everything is going up. But BCBSA is less sanguine; it thinks the coding is part of a strategy, and it thinks AI is driving that strategy.

“If patients are truly sicker, we’d expect to see more treatment,” said Luke Chalker, BCBSA’s senior vice president of product and data science. “For example, we’re seeing significantly more anemia diagnoses at these hospitals without a corresponding increase in transfusions. The disconnect between diagnoses and treatment suggests that AI is identifying more billable conditions, not sicker patients.”

The analysis indicated that most (70%) of the increased costs came from secondary diagnoses that shifted payment into higher reimbursement categories, so the hypothesis is plausible.

The American Hospital Association, of course, is having none of it. An August 2026 ”fact sheet” on AI and coding intensity called claims of AI driving coding intensity “unsubstantiated,” citing numerous factors that drive coding intensity. It blamed insurers for having AI-supported “downcoding programs,” the purpose of which are “to arbitrarily and inappropriately reduce provider reimbursement for medically necessary care that has already been delivered.”

AHA also snarkily but accurately noted how many Medicare Advantage plans have been caught upcoding members to boost their Medicare payments, so it depends on where one is sitting.

It’s also worth noting that this year the Trump Administration rolled out a Medicare program — Wasteful and Inappropriate Service Reduction (WISeR) – to use AI to help identify “fraud, waste and abuse” – a.k.a., deny claims. It has not, to say the least, gone well.

Both sides are using AI, to each other’s detriment. Which is to say, our detriment.

Continue reading…

You Say “AI,” I Hear “Organoid”

By KIM BELLARD

I must admit, ever since I learned about, and wrote about (OI May Be the New AI), “organoid intelligence” over three years ago, I’ve been looking to do a follow-up. I mean, sure, AI is in a very exciting stage, but that stage no longer seems like the future; it seems more like the present, with implementation issues. It’s data centers, hacking, impacts on jobs, open weight versus closed, and so on.  It’s market share, IPOs, and AI’s role in driving the stock market. People should certainly pay attention to it, but AI is not quite the open field that it was just a few years ago.

Organoids, on the other hand, are not quite here yet. They may – or may not – be the future of AI, among other things. I always like to look ahead to the next thing more than the at-hand, so when I saw some cool developments with organoids, I didn’t want to miss my chance.

Making some news last week, researchers at Harvard reported that they’d kept lab grown human brain organoids alive for over five years, three times the previous record. Not only that, but the organoids seem to “retain a memory of the time spent in vitro,” recording the passage of time, as it were.

“We didn’t know how far the development and maturation of human brain tissue could occur outside the context of the normal brain inside the head,” said Paola Arlotta, Golub Family Professor of Stem Cell and Regenerative Biology and senior author of the new paper. “This work showed that it’s actually possible to not just have these organoids survive in culture, but also continue to change, develop, and mature over stretches of time that had never been reached before.”

The team observed the organoid cells over the years, and found that they “faithfully modeled” the ways that human brain cells develop, including DNA methylation, a process in which genes are turned on and off during development, and which serve as a form of “brain clock.” When older and younger organoid cells were combined in a single organoid, the older cells stuck to the developmental stage they had been at, which researchers concluded meant they “recorded the passage of time and retain a memory of the developmental steps already performed.”

“We were a little bit shocked by the results,” Professor Arlotta said. “I like to call this a ‘time warp’ of development — they skip ahead.”

It’s obviously hard, and often unethical, to study actual human brain cells, so the researchers believe the organoids offer opportunities for more insights into brain development, as well as for testing drugs or predicting disease progression.

OK, you might say, that’s all very interesting and some great lab work, but it’s hardly AI, now is it?

Try this: last week The Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), DayOne, a Singapore-headquartered global data center developer and operator, and Cortical Labs, a Melbourne-based biological computing startup, announced they were partnering to form a Biological Data Center Prototype. The Center uses Cortical Labs’ CL1 biological computing system to offer “practical, sustainability-aligned alternative to conventional silicon infrastructure in Singapore through wetware-based computing.”

Continue reading…

Know Thyselves

By KIM BELLARD

With all the fuss about A.I. I was pleased to find some studies that illustrate that we don’t even fully understand the human brain yet. The ancient Greeks had a maxim “Know Thyself,” but the current research suggests they should have advised that we should “Know Thyselves.”

A new study from Stanford Medicine suggests that our brain is actually two separate organs: “…we postulate the brain is a composite organ emanating from two lineage-restricted progenitors; these dual progenitors may be evolutionarily conserved across 550 million years from hemichordates to mammals.”

Say what?

Now, let me make this clear: they’re not saying that the brain evolved from two separate organs into the brain we have today; they’re going a step further and saying there are still two separate organs, working together or in parallel. Freud must be feeling vindicated.

The press release says:

The new research finding shows that the human brain consists of two ancient nervous systems cleverly packaged together — a more primitive part that regulates our hearts’ beating, our breathing and other functions, and another that makes us distinctly human, capable of poetry, mathematics and wondering about our own origins.

“We’ve shown for the first time that the front of the brain arises from a totally different progenitor cell than the back of the brain,” said Kyle Loh, PhD, associate professor of developmental biology. “Our discovery means that we can now grow neurons from the back of the brain, the hindbrain, in a petri dish and study their functions.”

If you’re wondering why growing neurons from the hindbrain matters, it turns out that diseases that impact the brain stem, such as spinal muscular atrophy (also known as SMA) and amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig’s disease), have been hard to study because of the difficulty of growing such neurons in the lab. The researchers discovered the hindbrain follows a separate developmental path, running in parallel to — rather than branching off from — the pathway that creates the forebrain and midbrain.

“Previous attempts to make hindbrain neurons likely tried to coax forebrain and midbrain progenitors into hindbrain cells, which our study shows is not possible,” co-first author Rayyan Jokhai said. He added: “Now we have a model to better understand these devastating diseases, and work toward regenerative therapies for them. This is a very exciting new frontier in brain research.”

The researchers looked at various organisms and found that the separate systems date back over 500 million years. “Our research suggests that evolution took two existing neural systems and pushed them together spatially,” Professor Loh said. “Having the brain as one organ would probably be more efficient, but we rely on this primordial way to make the brain as two separate pieces.”

“I was surprised at our findings because the word ‘brain’ implies a contiguous organ that likely has a singular origin,” Mr. Jokhai said. “But even 500 million years ago, there were these separate neural systems, which now almost operate as one, which is very cool.”

Very cool, indeed.

Continue reading…

Start Counting Your Days

By KIM BELLARD

Probably the last thing the world needs is to hear from me about AI’s existential threat, but, really, what else is there to talk about right now?

For anyone who has not been following the current furor, the straw that broke the proverbial camel’s back came last week when Jacob Coxon, a researcher at AI leader Anthropic, announced he was leaving the company — after having left OpenAI for it earlier this year due to Anthropic’s better model-safety efforts. In a post on X, he warned:

I spent the last three years doing pretraining research at both OpenAI and Anthropic. Neither company is acting responsibly. They are racing straight to self-improving superintelligence and gambling with our lives.

AI systems, he fears, “will soon be superhuman systems that can hack anything, revolutionize any field overnight, and acquire real power and resources.” Insiders, he says, “earnestly believe it could kill us all by the end of the decade.”

Scared yet?

Others quickly chimed in. Evan Hubinger , a team leader at Anthropic, posted “AI could kill all humans … I personally think it is >10% within the next decade.”  Others put the risk even higher. By the end of the week Dario Anodei, founder and CEO of Anthropic, had written a long plea for private industry and government to quickly act together to “pace the industry.”

“We must slow the pace at which we improve the capabilities of AI models,” he urged. “Progress will still seem fast, and we must make wise use of the time we gain.”

OpenAI’s Sam Altman, Space X/X/Tesla CEO Elon Musk, Microsoft CEO Satya Nadella, and former Google DeepMind Dennis Hassabis quickly signaled their support.  

We also heard more about the kind of risks AI might pose. Anthropic released a report about how it detected and countered possible AI use to create bioweapons, detailing five such efforts. That’s just the tip of the iceberg: “Recently, we swept 30 days of activity associated with adversarial state institutions and found roughly 35 distinct research efforts, most of them ordinary civilian science, but some with notable dual-use potential.”

And it turns out that this summer’s rogue AI hack of Hugging Face was both scarier than we realized and only one of several such actions. The Wall Street Journal detailed several such efforts, from multiple AI companies. AI agents escaped walled-off environments, coordinated with other AI agents (up to 3,700 in one case), and tried to cover their tracks from humans.

We’re not nearing the point when AI can act on its own to achieve its purposes; we are there. And protecting humans may not necessarily be those purposes.

The big fear is that AI is now at the point of “recursive self-improvement,” taking humans out of the loop in training and upgrading it. If you thought artificial general intelligence (AGI) was scary, RGI puts its rate and scope of improvement on steroids.  “It’s hard to overstate how dangerous speeding towards RSI is,” said Jasmine Wang, an OpenAI researcher.  

We don’t let private industry develop nuclear or biochemical weapons, and we’re at a point with AI that should give the same kind of concern. Laissez-faire is no longer an option.

Continue reading…

Universal Coverage Might Be Nice, but an AI Tax Is Necessary

By KIM BELLARD

I was amused – oh, I should be polite and say “interested” — to see a new study, led by researchers from Yale School of Public Medicine, about the benefits of a universal single payor health system. It concluded that we could save 100,000 lives annually and save some 1.04 trillion each year – some 20% of our health care spending. What’s not to like? I’m sure Bernie Sanders is already drafting the bill.

The savings come from five sources: using Medicare payment rates for all providers, using “international reference pricing” for pharmaceuticals, reducing administrative costs to Medicare’s levels, reducing fraudulent billing (“consistent with the experience of other single-payer transitions”), and reducing emergency room visits and hospitalizations due to improved access to primary care.  Good goals, all.

Steffie Woolhandler and David Himmelstein, among others, have been making these or similar arguments for decades, and they are not without merit. It is shameful that we don’t have universal coverage. It is distressing how much money we spend on healthcare. It is embarrassing that we spend so much money on administration.  It is maddening that so many people don’t get the care they need, get the wrong care, or get their care in the wrong places/at the wrong times.

We could do better, we should do better, but, if anything, we’re doing worse: more people are losing coverage, more providers are going out of business, our rates of chronic (and some infectious diseases) are going up, and we’re dying sooner.

I want to quickly point out some of the problems with the proposed sources of savings, then discuss other courses of action that might lead to these or even better outcomes.

  • Medicare payment rates: yes, a lot of money could be saved by using Medicare payment rates, but I doubt you would find many providers who would say they could survive. They make their money on private insurance rates, are lucky to break even on Medicare rates, and lose money on Medicaid. This one is not going to happen.
  • International pharmaceutical reference pricing: first, I’m not sure such a thing exists. It is true that drug prices are typically lower in other countries. Both President Biden and President Trump seized upon this, with some signs of modest success. But, as with the Medicare pricing, it would be a shock to the pharmaceutical industry to have prices slashed across the board, wiping out trillions of dollars of value and, oh-by-the-way, eventually reducing investments on new and better prescriptions.
  • Administrative costs: as a percentage of spending, Medicare’s administrative costs are lower than private insurance, but that is partly due to Medicare spending per capita being so much higher. Also, costs incurred by other agencies – e.g., Social Security or the IRS – are not always counted. But certainly the complexities of so many plan designs by so many health insurers while tracking the current eligibility of everyone is a cost that is much higher than it should be.
  • Reducing fraudulent billing: I mean, really: do people really think that Medicare does a better job of reducing fraudulent billing than United Healthcare or Anthem, much less than other countries?
  • More primary care: reducing emergency room visits and hospitalizations has been the goal of countless private health insurance efforts, such as disease management or chronic health programs, and the track record has generally been underwhelming. But the real problem is – where are we going to get all the primary care physicians to handle all the underserved people?  

So, much as I agree with the goals, count me a skeptic that single payor is going to magically make everything better.

Here’s where I inevitably turn to AI.

Continue reading…

Work Requirements Target the Wrong People

By KIM BELLARD

One of the key “cost savings” in last years’ Big, Beautiful Bill were work requirements imposed on most working aged beneficiaries in SNAP and/or Medicaid, despite the fact that the few times such requirements had been tried showed they were costly to implement and operate and don’t do much to increase work participation, although they are effective at getting beneficiaries to lose benefits. Republicans who pushed these requirements were infuriated at the thought that some able-bodied people – stereotypically young men – were sitting around on their couches playing video games while benefiting from the programs, despite those programs’ complex administrative burdens and meagre benefits.

A new GAO report reminds us that the people coasting off SNAP and Medicaid were not so much the beneficiaries but rather employers, especially large employers. And the names of the most likely employers won’t come as a big surprise.

The report — Federal Social Safety Net Programs: Millions of Workers, Including Many Employed by Large Employers, Continue to Rely on Medicaid and SNAP – was requested by Senator Bernie Sanders, in his role as Ranking Member of the Senate Committee on Health, Education, Labor, and Pensions, and is a follow-up to a similar 2020 report. It focused on 11 states: Arkansas, Georgia, Indiana, Maine, Massachusetts, Nebraska, North Carolina, Oklahoma, Rhode Island, Tennessee, and Washington.

The top-lines are that working aged beneficiaries in both programs were, in fact, not only likely to already be working—mostly full-time — but also at participation rates higher than working aged people not on the programs, and that companies like Amazon and Walmart were among the largest employers of these beneficiaries.

The key change in employment in these populations has been the explosion of gig workers in the app-based food delivery and ride sharing sectors. Workers at Amazon on these programs also tripled since the prior report. Walmart remains the employer with the largest number of these workers who receive Medicaid, but has slipped to second to ride sharing gig workers receiving SNAP. McDonalds and Dollar General round out the top five employers.  

Now, these are among the largest employers generally, but, gosh, doesn’t it gall you that have so many of their workers who still need SNAP and/or Medicaid?  It’s not like they’re not making money, it’s not that their CEOs and other executives aren’t raking in tens of millions of dollars, but they sure are reluctant to pay federal income taxes. The Wall Street Journal reported earlier this year that, as a result of The Big, Beautiful Bill, Amazon’s federal income taxes dropped from $9b to $1.2b in 2025, while profits soared 44.5% to $90b. Walmart looks like a sucker for paying $6b in 2025, an effective tax rate of about 23%.

An Amazon spokesperson defended its practices in a response to The Washington Post: “Amazon pay is among the best in the industry, regular full-time employees have access to health care from their first day … and 74% of our regular full-time employees are enrolled in an Amazon health insurance plan, well above the 65% private sector take-up rate for full-time workers.”

So, if all those employees have access to coverage from their first day and get among the best pay in the industry, why are any on SNAP or Medicaid?  And couldn’t you at least pay more than 1.3% on federal taxes?

Bernie, of course, was outraged:

Continue reading…